目的 分析華中科技大學(xué)同濟(jì)醫(yī)學(xué)院附屬協(xié)和醫(yī)院腫瘤中心2013—2015年抗腫瘤藥的應(yīng)用情況，為臨床合理用藥提供參考依據(jù)。方法 按照藥品類型和品種對(duì)華中科技大學(xué)同濟(jì)醫(yī)學(xué)院附屬協(xié)和醫(yī)院腫瘤中心抗腫瘤藥物的使用金額、用藥頻率（DDDs）和日均用藥費(fèi)用（DDC）等進(jìn)行統(tǒng)計(jì)，分析抗腫瘤藥的應(yīng)用現(xiàn)狀。結(jié)果 2013—2015年應(yīng)用抗腫瘤藥6亞類，用藥金額、DDDs總體呈上升趨勢(shì)，3年中其他抗腫瘤藥在用藥金額、DDDs和品種數(shù)3項(xiàng)指標(biāo)上均位居首位，培美曲塞的用藥金額3年來(lái)穩(wěn)居榜首，多西他賽和他莫西芬的DDDs最高。結(jié)論 華中科技大學(xué)同濟(jì)醫(yī)學(xué)院附屬協(xié)和醫(yī)院腫瘤中心抗腫瘤藥的用藥現(xiàn)狀符合當(dāng)前國(guó)內(nèi)該類藥品消耗總趨勢(shì)，使用情況基本合理。

Objective To evaluate the characteristics of antineoplastic agents in Tumor Center of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology from 2013 to 2015, and to provide references for the rationally clinical application of these drugs. Methods The utilization of antineoplastic agents in Tumor Center of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology was analyzed statistically by drug types and categories in respects of consumption sum, DDDs, DDC, etc.Results From 2013 to 2015, 6 subcategories of antineoplastic agents were used, showing a general increasing trend in both consumption sum and DDDs. The other antineoplastic agents took the lead in consumption sum, DDDs, and the number of drugs. Consumption sum of pemetrexed ranked the first, and DDDs of docetaxe and tamoxifen were the highest. Conclusion The use of antineoplastic agents in Tumor Center of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology is rational basically, and it is in conformity with the general consumption tendency of this kind of drugs in China.